This effect has been mechanistically implicated in the development of liver disease upon deletion of Stat5 (Hosui et al. 2009), demonstrating that the role of JAK/STAT signaling in progressive NAFLD involves a regulatory function that is more complex than simple gain or loss of function of the entire pathway. The gene discussed is SOAT1; the disease is metabolic dysfunction-associated steatotic liver disease.